메뉴 건너뛰기




Volumn 64, Issue 9, 2015, Pages 1159-1173

Phase I trial of thymidylate synthase poly-epitope peptide (TSPP) vaccine in advanced cancer patients

Author keywords

Cancer vaccine; CTLs; Immune response; Immunotherapy; Phase Ib trial

Indexed keywords

CYTOKINE; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 2; PEPTIDE VACCINE; THYMIDYLATE SYNTHASE POLYEPITOPE PEPTIDE; UNCLASSIFIED DRUG; CANCER VACCINE; SUBUNIT VACCINE; THYMIDYLATE SYNTHASE;

EID: 84939562827     PISSN: 03407004     EISSN: 14320851     Source Type: Journal    
DOI: 10.1007/s00262-015-1711-7     Document Type: Article
Times cited : (21)

References (48)
  • 1
    • 70349233050 scopus 로고    scopus 로고
    • Cancer immunotherapy
    • COI: 1:CAS:528:DC%2BD1MXptlKnsbs%3D, PID: 19650714
    • Baxevanis CN, Perez SA, Papamichail M (2009) Cancer immunotherapy. Crit Rev Clin Lab Sci 46(4):167–189. doi:10.1080/10408360902937809
    • (2009) Crit Rev Clin Lab Sci , vol.46 , Issue.4 , pp. 167-189
    • Baxevanis, C.N.1    Perez, S.A.2    Papamichail, M.3
  • 2
    • 78650919399 scopus 로고    scopus 로고
    • Translating tumor antigens into cancer vaccines
    • COI: 1:CAS:528:DC%2BC3MXpslWntA%3D%3D, PID: 21048000
    • Buonaguro L, Petrizzo A, Tornesello ML, Buonaguro FM (2011) Translating tumor antigens into cancer vaccines. Clin Vaccine Immunol 18(1):23–34. doi:10.1128/CVI.00286-10
    • (2011) Clin Vaccine Immunol , vol.18 , Issue.1 , pp. 23-34
    • Buonaguro, L.1    Petrizzo, A.2    Tornesello, M.L.3    Buonaguro, F.M.4
  • 3
    • 84865694926 scopus 로고    scopus 로고
    • New anticancer immunotherapies
    • COI: 1:CAS:528:DC%2BC38Xht1aks7%2FF, PID: 22753700
    • Franks HA, Wang Q, Patel PM (2012) New anticancer immunotherapies. Anticancer Res 32(7):2439–2453
    • (2012) Anticancer Res , vol.32 , Issue.7 , pp. 2439-2453
    • Franks, H.A.1    Wang, Q.2    Patel, P.M.3
  • 4
    • 79957709717 scopus 로고    scopus 로고
    • Vaccines for the treatment of non-small cell lung cancer: investigational approaches and clinical experience
    • PID: 21474197
    • Mellstedt H, Vansteenkiste J, Thatcher N (2011) Vaccines for the treatment of non-small cell lung cancer: investigational approaches and clinical experience. Lung Cancer 73(1):11–17. doi:10.1016/j.lungcan.2011.02.023
    • (2011) Lung Cancer , vol.73 , Issue.1 , pp. 11-17
    • Mellstedt, H.1    Vansteenkiste, J.2    Thatcher, N.3
  • 5
    • 71949118684 scopus 로고    scopus 로고
    • Peptide-based anticancer vaccines: recent advances and future perspectives
    • COI: 1:CAS:528:DC%2BC3cXhsVSmsbY%3D, PID: 19929787
    • Mocellin S, Pilati P, Nitti D (2009) Peptide-based anticancer vaccines: recent advances and future perspectives. Curr Med Chem 16(36):4779–4796
    • (2009) Curr Med Chem , vol.16 , Issue.36 , pp. 4779-4796
    • Mocellin, S.1    Pilati, P.2    Nitti, D.3
  • 6
    • 0028298850 scopus 로고
    • Tumour antigens. A new look for the 1990s
    • COI: 1:STN:280:DyaK2c3lsFSjug%3D%3D, PID: 8018207
    • Pardoll DM (1994) Tumour antigens. A new look for the 1990s. Nature 369(6479):357. doi:10.1038/369357a0
    • (1994) Nature , vol.369 , Issue.6479 , pp. 357
    • Pardoll, D.M.1
  • 7
    • 0029924107 scopus 로고    scopus 로고
    • Human tumor antigens recognized by T lymphocytes
    • COI: 1:CAS:528:DyaK28XhvV2rur8%3D, PID: 8642276
    • Boon T, van der Bruggen P (1996) Human tumor antigens recognized by T lymphocytes. J Exp Med 183(3):725–729
    • (1996) J Exp Med , vol.183 , Issue.3 , pp. 725-729
    • Boon, T.1    van der Bruggen, P.2
  • 9
    • 84867304928 scopus 로고    scopus 로고
    • Transcriptional activation and cell cycle block are the keys for 5-fluorouracil induced up-regulation of human thymidylate synthase expression
    • COI: 1:CAS:528:DC%2BC38XhsFCku73I, PID: 23056627
    • Ligabue A, Marverti G, Liebl U, Myllykallio H (2012) Transcriptional activation and cell cycle block are the keys for 5-fluorouracil induced up-regulation of human thymidylate synthase expression. Plos One 7(10):e47318. doi:10.1371/journal.pone.0047318
    • (2012) Plos One , vol.7 , Issue.10 , pp. e47318
    • Ligabue, A.1    Marverti, G.2    Liebl, U.3    Myllykallio, H.4
  • 10
    • 23244464739 scopus 로고    scopus 로고
    • Thymidylate synthase: a critical target in cancer therapy?
    • COI: 1:CAS:528:DC%2BD2cXltl2nu7Y%3D, PID: 15353299
    • Rustum YM (2004) Thymidylate synthase: a critical target in cancer therapy? Front Biosci 9:2467–2473
    • (2004) Front Biosci , vol.9 , pp. 2467-2473
    • Rustum, Y.M.1
  • 11
    • 0028265392 scopus 로고
    • New targets for pyrimidine antimetabolites in the treatment of solid tumours. 1: thymidylate synthase
    • PID: 7518280
    • van der Wilt CL, Peters GJ (1994) New targets for pyrimidine antimetabolites in the treatment of solid tumours. 1: thymidylate synthase. Pharm World Sci 16(2):84–103
    • (1994) Pharm World Sci , vol.16 , Issue.2 , pp. 84-103
    • van der Wilt, C.L.1    Peters, G.J.2
  • 16
    • 23244464772 scopus 로고    scopus 로고
    • Dendritic cell-mediated cross-presentation of antigens derived from colon carcinoma cells exposed to a highly cytotoxic multidrug regimen with gemcitabine, oxaliplatin, 5-fluorouracil, and leucovorin, elicits a powerful human antigen-specific CTL response with antitumor activity in vitro
    • COI: 1:CAS:528:DC%2BD2MXlvFSjsbo%3D, PID: 16002679
    • Correale P, Cusi MG, Del Vecchio MT, Aquino A, Prete SP, Tsang KY, Micheli L, Nencini C, La Placa M, Montagnani F, Terrosi C, Caraglia M, Formica V, Giorgi G, Bonmassar E, Francini G (2005) Dendritic cell-mediated cross-presentation of antigens derived from colon carcinoma cells exposed to a highly cytotoxic multidrug regimen with gemcitabine, oxaliplatin, 5-fluorouracil, and leucovorin, elicits a powerful human antigen-specific CTL response with antitumor activity in vitro. J Immunol 175(2):820–828
    • (2005) J Immunol , vol.175 , Issue.2 , pp. 820-828
    • Correale, P.1    Cusi, M.G.2    Del Vecchio, M.T.3    Aquino, A.4    Prete, S.P.5    Tsang, K.Y.6    Micheli, L.7    Nencini, C.8    La Placa, M.9    Montagnani, F.10    Terrosi, C.11    Caraglia, M.12    Formica, V.13    Giorgi, G.14    Bonmassar, E.15    Francini, G.16
  • 18
    • 33644789357 scopus 로고    scopus 로고
    • Chemo-immunotherapy of metastatic colorectal carcinoma with gemcitabine plus FOLFOX 4 followed by subcutaneous granulocyte macrophage colony-stimulating factor and interleukin-2 induces strong immunologic and antitumor activity in metastatic colon cancer patients
    • COI: 1:CAS:528:DC%2BD28XktVCguw%3D%3D, PID: 16061910
    • Correale P, Cusi MG, Tsang KY, Del Vecchio MT, Marsili S, Placa ML, Intrivici C, Aquino A, Micheli L, Nencini C, Ferrari F, Giorgi G, Bonmassar E, Francini G (2005) Chemo-immunotherapy of metastatic colorectal carcinoma with gemcitabine plus FOLFOX 4 followed by subcutaneous granulocyte macrophage colony-stimulating factor and interleukin-2 induces strong immunologic and antitumor activity in metastatic colon cancer patients. J Clin Oncol 23(35):8950–8958. doi:10.1200/JCO.2005.12.147
    • (2005) J Clin Oncol , vol.23 , Issue.35 , pp. 8950-8958
    • Correale, P.1    Cusi, M.G.2    Tsang, K.Y.3    Del Vecchio, M.T.4    Marsili, S.5    Placa, M.L.6    Intrivici, C.7    Aquino, A.8    Micheli, L.9    Nencini, C.10    Ferrari, F.11    Giorgi, G.12    Bonmassar, E.13    Francini, G.14
  • 19
    • 48249096809 scopus 로고    scopus 로고
    • Immunity feedback and clinical outcome in colon cancer patients undergoing chemoimmunotherapy with gemcitabine + FOLFOX followed by subcutaneous granulocyte macrophage colony-stimulating factor and aldesleukin (GOLFIG-1 Trial)
    • COI: 1:CAS:528:DC%2BD1cXnvFyksro%3D, PID: 18593999
    • Correale P, Tagliaferri P, Fioravanti A, Del Vecchio MT, Remondo C, Montagnani F, Rotundo MS, Ginanneschi C, Martellucci I, Francini E, Cusi MG, Tassone P, Francini G (2008) Immunity feedback and clinical outcome in colon cancer patients undergoing chemoimmunotherapy with gemcitabine + FOLFOX followed by subcutaneous granulocyte macrophage colony-stimulating factor and aldesleukin (GOLFIG-1 Trial). Clin Cancer Res 14(13):4192–4199. doi:10.1158/1078-0432.CCR-07-5278
    • (2008) Clin Cancer Res , vol.14 , Issue.13 , pp. 4192-4199
    • Correale, P.1    Tagliaferri, P.2    Fioravanti, A.3    Del Vecchio, M.T.4    Remondo, C.5    Montagnani, F.6    Rotundo, M.S.7    Ginanneschi, C.8    Martellucci, I.9    Francini, E.10    Cusi, M.G.11    Tassone, P.12    Francini, G.13
  • 20
    • 0037379110 scopus 로고    scopus 로고
    • Multidisciplinary utilization of dimethyl sulfoxide: pharmacological, cellular, and molecular aspects
    • COI: 1:CAS:528:DC%2BD3sXit12gur0%3D, PID: 12663039
    • Santos NC, Figueira-Coelho J, Martins-Silva J, Saldanha C (2003) Multidisciplinary utilization of dimethyl sulfoxide: pharmacological, cellular, and molecular aspects. Biochem Pharmacol 65(7):1035–1041
    • (2003) Biochem Pharmacol , vol.65 , Issue.7 , pp. 1035-1041
    • Santos, N.C.1    Figueira-Coelho, J.2    Martins-Silva, J.3    Saldanha, C.4
  • 21
    • 0042914645 scopus 로고    scopus 로고
    • Modified fibonacci search
    • PID: 12915613
    • Omura GA (2003) Modified fibonacci search. J Clin Oncol 21(16):3177. doi:10.1200/JCO.2003.99.058
    • (2003) J Clin Oncol , vol.21 , Issue.16 , pp. 3177
    • Omura, G.A.1
  • 23
    • 0014385954 scopus 로고
    • A one-stage procedure for isolation of granulocytes and lymphocytes from human blood. General sedimentation properties of white blood cells in a 1g gravity field
    • COI: 1:STN:280:DyaF1M7gtFKrtw%3D%3D
    • Boyum A (1968) A one-stage procedure for isolation of granulocytes and lymphocytes from human blood. General sedimentation properties of white blood cells in a 1g gravity field. Scand J Clin Lab Investig Suppl 97:51–76
    • (1968) Scand J Clin Lab Investig Suppl , vol.97 , pp. 51-76
    • Boyum, A.1
  • 24
    • 0021020342 scopus 로고
    • A solid-phase enzyme-linked immunospot (ELISPOT) assay for enumeration of specific antibody-secreting cells
    • COI: 1:STN:280:DyaL2c%2FovFSgtA%3D%3D, PID: 6361139
    • Czerkinsky CC, Nilsson LA, Nygren H, Ouchterlony O, Tarkowski A (1983) A solid-phase enzyme-linked immunospot (ELISPOT) assay for enumeration of specific antibody-secreting cells. J Immunol Methods 65(1–2):109–121
    • (1983) J Immunol Methods , vol.65 , Issue.1-2 , pp. 109-121
    • Czerkinsky, C.C.1    Nilsson, L.A.2    Nygren, H.3    Ouchterlony, O.4    Tarkowski, A.5
  • 27
    • 0030918409 scopus 로고    scopus 로고
    • Validation of the EORTC QLQ-C30 quality of life questionnaire through combined qualitative and quantitative assessment of patient-observer agreement
    • COI: 1:STN:280:DyaK2szit1KisQ%3D%3D, PID: 9179103
    • Groenvold M, Klee MC, Sprangers MA, Aaronson NK (1997) Validation of the EORTC QLQ-C30 quality of life questionnaire through combined qualitative and quantitative assessment of patient-observer agreement. J Clin Epidemiol 50(4):441–450
    • (1997) J Clin Epidemiol , vol.50 , Issue.4 , pp. 441-450
    • Groenvold, M.1    Klee, M.C.2    Sprangers, M.A.3    Aaronson, N.K.4
  • 28
    • 79959201922 scopus 로고    scopus 로고
    • Myeloperoxidase: the yin and yang in tumour progression
    • COI: 1:CAS:528:DC%2BC3MXot1Oqtbk%3D, PID: 21699016
    • Mika D, Guruvayoorappan C (2011) Myeloperoxidase: the yin and yang in tumour progression. J Exp Ther Oncol 9(2):93–100
    • (2011) J Exp Ther Oncol , vol.9 , Issue.2 , pp. 93-100
    • Mika, D.1    Guruvayoorappan, C.2
  • 29
    • 77950346282 scopus 로고    scopus 로고
    • Immunity, inflammation, and cancer
    • COI: 1:CAS:528:DC%2BC3cXlsVSgu7g%3D, PID: 20303878
    • Grivennikov SI, Greten FR, Karin M (2010) Immunity, inflammation, and cancer. Cell 140(6):883–899. doi:10.1016/j.cell.2010.01.025
    • (2010) Cell , vol.140 , Issue.6 , pp. 883-899
    • Grivennikov, S.I.1    Greten, F.R.2    Karin, M.3
  • 31
    • 84874921468 scopus 로고    scopus 로고
    • Heat shock proteins, autoimmunity, and cancer treatment
    • PID: 23056925
    • Calderwood SK, Stevenson MA, Murshid A (2012) Heat shock proteins, autoimmunity, and cancer treatment. Autoimmune Dis 2012:486069. doi:10.1155/2012/486069
    • (2012) Autoimmune Dis , vol.2012 , pp. 486069
    • Calderwood, S.K.1    Stevenson, M.A.2    Murshid, A.3
  • 32
    • 84865552100 scopus 로고    scopus 로고
    • Immuno-oncology: understanding the function and dysfunction of the immune system in cancer
    • PID: 22918931
    • Finn OJ (2012) Immuno-oncology: understanding the function and dysfunction of the immune system in cancer. Ann Oncol 23(Suppl 8):viii6–viii9. doi:10.1093/annonc/mds256
    • (2012) Ann Oncol , vol.23 , pp. viii6-viii9
    • Finn, O.J.1
  • 33
    • 80052981497 scopus 로고    scopus 로고
    • Cancer vaccines inducing antibody production: more pros than cons
    • COI: 1:CAS:528:DC%2BC3MXhtFOju7vP, PID: 21919618
    • Jensen-Jarolim E, Singer J (2011) Cancer vaccines inducing antibody production: more pros than cons. Expert Rev Vaccines 10(9):1281–1289. doi:10.1586/erv.11.105
    • (2011) Expert Rev Vaccines , vol.10 , Issue.9 , pp. 1281-1289
    • Jensen-Jarolim, E.1    Singer, J.2
  • 34
    • 47949096781 scopus 로고    scopus 로고
    • Cancer-related inflammation
    • COI: 1:CAS:528:DC%2BD1cXovV2mtbg%3D, PID: 18650914
    • Mantovani A, Allavena P, Sica A, Balkwill F (2008) Cancer-related inflammation. Nature 454(7203):436–444. doi:10.1038/nature07205
    • (2008) Nature , vol.454 , Issue.7203 , pp. 436-444
    • Mantovani, A.1    Allavena, P.2    Sica, A.3    Balkwill, F.4
  • 36
    • 84892740595 scopus 로고    scopus 로고
    • Immunomodulatory effects in a phase II study of lenalidomide combined with cetuximab in refractory KRAS-mutant metastatic colorectal cancer patients
    • COI: 1:CAS:528:DC%2BC3sXhslyls7nF, PID: 24244687
    • Gandhi AK, Shi T, Li M, Jungnelius U, Romano A, Tabernero J, Siena S, Schafer PH, Chopra R (2013) Immunomodulatory effects in a phase II study of lenalidomide combined with cetuximab in refractory KRAS-mutant metastatic colorectal cancer patients. Plos One 8(11):e80437. doi:10.1371/journal.pone.0080437
    • (2013) Plos One , vol.8 , Issue.11 , pp. e80437
    • Gandhi, A.K.1    Shi, T.2    Li, M.3    Jungnelius, U.4    Romano, A.5    Tabernero, J.6    Siena, S.7    Schafer, P.H.8    Chopra, R.9
  • 38
    • 84875280049 scopus 로고    scopus 로고
    • Advance lung cancer inflammation index (ALI) at diagnosis is a prognostic marker in patients with metastatic non-small cell lung cancer (NSCLC): a retrospective review
    • PID: 23530866
    • Jafri SH, Shi R, Mills G (2013) Advance lung cancer inflammation index (ALI) at diagnosis is a prognostic marker in patients with metastatic non-small cell lung cancer (NSCLC): a retrospective review. BMC Cancer 13:158. doi:10.1186/1471-2407-13-158
    • (2013) BMC Cancer , vol.13 , pp. 158
    • Jafri, S.H.1    Shi, R.2    Mills, G.3
  • 41
    • 84860798836 scopus 로고    scopus 로고
    • The regulation of the development and function of dendritic cell subsets by GM-CSF: more than a hematopoietic growth factor
    • COI: 1:CAS:528:DC%2BC38XnsFOqsbg%3D, PID: 22580403
    • Zhan Y, Xu Y, Lew AM (2012) The regulation of the development and function of dendritic cell subsets by GM-CSF: more than a hematopoietic growth factor. Mol Immunol 52(1):30–37. doi:10.1016/j.molimm.2012.04.009
    • (2012) Mol Immunol , vol.52 , Issue.1 , pp. 30-37
    • Zhan, Y.1    Xu, Y.2    Lew, A.M.3
  • 42
    • 84915817439 scopus 로고    scopus 로고
    • Myeloid-derived suppressor cells in multiple myeloma: pre-clinical research and translational opportunities
    • PID: 25538892
    • Botta C, Gulla A, Correale P, Tagliaferri P, Tassone P (2014) Myeloid-derived suppressor cells in multiple myeloma: pre-clinical research and translational opportunities. Front Oncol 4:348. doi:10.3389/fonc.2014.00348
    • (2014) Front Oncol , vol.4 , pp. 348
    • Botta, C.1    Gulla, A.2    Correale, P.3    Tagliaferri, P.4    Tassone, P.5
  • 43
    • 70249100293 scopus 로고    scopus 로고
    • Heterogeneity of CD4+ memory T cells: functional modules for tailored immunity
    • COI: 1:CAS:528:DC%2BD1MXhtVWrsrzJ, PID: 19672903
    • Sallusto F, Lanzavecchia A (2009) Heterogeneity of CD4+ memory T cells: functional modules for tailored immunity. Eur J Immunol 39(8):2076–2082. doi:10.1002/eji.200939722
    • (2009) Eur J Immunol , vol.39 , Issue.8 , pp. 2076-2082
    • Sallusto, F.1    Lanzavecchia, A.2
  • 44
    • 0033214348 scopus 로고    scopus 로고
    • CCR7 coordinates the primary immune response by establishing functional microenvironments in secondary lymphoid organs
    • COI: 1:CAS:528:DyaK1MXmsleqs7o%3D, PID: 10520991
    • Forster R, Schubel A, Breitfeld D, Kremmer E, Renner-Muller I, Wolf E, Lipp M (1999) CCR7 coordinates the primary immune response by establishing functional microenvironments in secondary lymphoid organs. Cell 99(1):23–33
    • (1999) Cell , vol.99 , Issue.1 , pp. 23-33
    • Forster, R.1    Schubel, A.2    Breitfeld, D.3    Kremmer, E.4    Renner-Muller, I.5    Wolf, E.6    Lipp, M.7
  • 45
    • 2142730100 scopus 로고    scopus 로고
    • Central memory and effector memory T cell subsets: function, generation, and maintenance
    • COI: 1:CAS:528:DC%2BD2cXktlOgsb8%3D, PID: 15032595
    • Sallusto F, Geginat J, Lanzavecchia A (2004) Central memory and effector memory T cell subsets: function, generation, and maintenance. Annu Rev Immunol 22:745–763. doi:10.1146/annurev.immunol.22.012703.104702
    • (2004) Annu Rev Immunol , vol.22 , pp. 745-763
    • Sallusto, F.1    Geginat, J.2    Lanzavecchia, A.3
  • 47
    • 84879187714 scopus 로고    scopus 로고
    • Tumor infiltration by chemokine receptor 7 (CCR7)(+) T-lymphocytes is a favorable prognostic factor in metastatic colorectal cancer
    • PID: 22754775
    • Correale P, Rotundo MS, Botta C, Del Vecchio MT, Tassone P, Tagliaferri P (2012) Tumor infiltration by chemokine receptor 7 (CCR7)(+) T-lymphocytes is a favorable prognostic factor in metastatic colorectal cancer. Oncoimmunology 1(4):531–532
    • (2012) Oncoimmunology , vol.1 , Issue.4 , pp. 531-532
    • Correale, P.1    Rotundo, M.S.2    Botta, C.3    Del Vecchio, M.T.4    Tassone, P.5    Tagliaferri, P.6
  • 48
    • 43949105866 scopus 로고    scopus 로고
    • Regulatory T cells and immune tolerance
    • COI: 1:CAS:528:DC%2BD1cXntFaltrg%3D, PID: 18510923
    • Sakaguchi S, Yamaguchi T, Nomura T, Ono M (2008) Regulatory T cells and immune tolerance. Cell 133(5):775–787. doi:10.1016/j.cell.2008.05.009
    • (2008) Cell , vol.133 , Issue.5 , pp. 775-787
    • Sakaguchi, S.1    Yamaguchi, T.2    Nomura, T.3    Ono, M.4


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.